Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.

Rinta-Kokko H, Auranen K, Toropainen M, Nuorti JP, Nohynek H, Siira L, Palmu AA.

Vaccine. 2019 Nov 29. pii: S0264-410X(19)31591-9. doi: 10.1016/j.vaccine.2019.11.049. [Epub ahead of print]

PMID:
31791813
2.

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, Emonet S, Caugant DA, Toropainen M, Vazquez J, Waśko I, Knol MJ, Jacobsson S, Rodrigues Bettencourt C, Musilek M, Born R, Vogel U, Borrow R.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800245.

3.

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D.

Vaccine. 2019 Feb 8;37(7):991-1000. doi: 10.1016/j.vaccine.2018.12.061. Epub 2019 Jan 17.

4.

Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year.

Bratcher HB, Brehony C, Heuberger S, Pieridou-Bagatzouni D, Křížová P, Hoffmann S, Toropainen M, Taha MK, Claus H, Tzanakaki G, Erdôsi T, Galajeva J, van der Ende A, Skoczyńska A, Pana M, Vaculíková A, Paragi M, Maiden MC, Caugant DA.

Euro Surveill. 2018 May;23(20). doi: 10.2807/1560-7917.ES.2018.23.20.17-00474.

5.

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.

Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J.

Vaccine. 2018 Apr 5;36(15):1934-1940. doi: 10.1016/j.vaccine.2018.03.001. Epub 2018 Mar 8.

PMID:
29526371
6.

External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae.

Slotved HC, Sheppard CL, Dalby T, van der Ende A, Fry NK, Morfeldt E, Nyholm O, Rokney A, Ron M, Siira L, Scott KJ, Smith A, Thom L, Toropainen M, Vestrheim DF.

Sci Rep. 2017 Oct 16;7(1):13280. doi: 10.1038/s41598-017-13605-8.

7.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
8.

Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland.

Sihvonen R, Siira L, Toropainen M, Kuusela P, Pätäri-Sampo A.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2109-2116. doi: 10.1007/s10096-017-3033-5. Epub 2017 Jun 13.

PMID:
28612153
9.

Bacterial meningitis in Finland, 1995-2014: a population-based observational study.

Polkowska A, Toropainen M, Ollgren J, Lyytikäinen O, Nuorti JP.

BMJ Open. 2017 Jun 6;7(5):e015080. doi: 10.1136/bmjopen-2016-015080.

10.

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J.

Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15.

11.

Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.

Bröker M, Emonet S, Fazio C, Jacobsson S, Koliou M, Kuusi M, Pace D, Paragi M, Pysik A, Simões MJ, Skoczynska A, Stefanelli P, Toropainen M, Taha MK, Tzanakaki G.

Hum Vaccin Immunother. 2015;11(9):2281-6. doi: 10.1080/21645515.2015.1051276.

12.

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP.

PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.

13.

[Invasive community-acquired infections in children].

Jenu S, Simons L, Pätäri-Sampo A, Toropainen M, Saxén H.

Duodecim. 2014;130(14):1445-51. Finnish.

PMID:
25158584
14.

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Brehony C, Trotter CL, Ramsay ME, Chandra M, Jolley KA, van der Ende A, Carion F, Berthelsen L, Hoffmann S, Harðardóttir H, Vazquez JA, Murphy K, Toropainen M, Caniça M, Ferreira E, Diggle M, Edwards GF, Taha MK, Stefanelli P, Kriz P, Gray SJ, Fox AJ, Jacobsson S, Claus H, Vogel U, Tzanakaki G, Heuberger S, Caugant DA, Frosch M, Maiden MC.

Clin Vaccine Immunol. 2014 Jun;21(6):847-53. doi: 10.1128/CVI.00133-14. Epub 2014 Apr 2.

15.

Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

Bröker M, Bukovski S, Culic D, Jacobsson S, Koliou M, Kuusi M, Simões MJ, Skoczynska A, Toropainen M, Taha MK, Tzanakaki G.

Hum Vaccin Immunother. 2014;10(6):1725-8. doi: 10.4161/hv.28206. Epub 2014 Mar 7.

16.

Pneumococcemia in children--a retrospective study before universal pneumococcal vaccinations.

Karppa H, Vuento R, Toropainen M, Kaijalainen T, Siira L, Korppi M.

Acta Paediatr. 2013 May;102(5):514-9. doi: 10.1111/apa.12194. Epub 2013 Feb 28.

PMID:
23398588
17.

Meningococcal serogroup Y emergence in Europe: update 2011.

Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, Skoczynska A, Taha MK, Toropainen M, Tzanakaki G.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1907-11. doi: 10.4161/hv.21794. Epub 2012 Oct 2.

18.

From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping.

Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A.

J Clin Microbiol. 2012 Aug;50(8):2727-31. doi: 10.1128/JCM.00689-12. Epub 2012 Jun 12.

19.

Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Jounio U, Saukkoriipi A, Bratcher HB, Bloigu A, Juvonen R, Silvennoinen-Kassinen S, Peitso A, Harju T, Vainio O, Kuusi M, Maiden MC, Leinonen M, Käyhty H, Toropainen M.

J Clin Microbiol. 2012 Feb;50(2):264-73. doi: 10.1128/JCM.05385-11. Epub 2011 Nov 30.

20.

Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.

Toropainen M, Raitolehto A, Henckaerts I, Wauters D, Poolman J, Lestrate P, Käyhty H.

Infect Immun. 2008 Oct;76(10):4546-53. doi: 10.1128/IAI.00418-08. Epub 2008 Jul 21.

21.

Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings.

Siljander T, Karppelin M, Vähäkuopus S, Syrjänen J, Toropainen M, Kere J, Vuento R, Jussila T, Vuopio-Varkila J.

Clin Infect Dis. 2008 Mar 15;46(6):855-61. doi: 10.1086/527388.

PMID:
18260753
22.

emm typing of invasive T28 group A streptococci, 1995-2004, Finland.

Siljander T, Toropainen M, Muotiala A, Hoe NP, Musser JM, Vuopio-Varkila J.

J Med Microbiol. 2006 Dec;55(Pt 12):1701-6.

PMID:
17108274
24.
25.
26.

Probing the ability of the coat and vertex protein of the membrane-containing bacteriophage PRD1 to display a meningococcal epitope.

Huiskonen JT, Laakkonen L, Toropainen M, Sarvas M, Bamford DH, Bamford JK.

Virology. 2003 Jun 5;310(2):267-79.

27.
28.

The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci.

Toropainen M, Käyhty H, Saarinen L, Rosenqvist E, Høiby EA, Wedege E, Michaelsen T, Mäkelä PH.

Vaccine. 1999 Jun 4;17(20-21):2677-89.

PMID:
10418919
29.

Behavioral sensitivity and ethanol potentiation of the N-methyl-D-aspartate receptor antagonist MK-801 in a rat line selected for high ethanol sensitivity.

Toropainen M, Näkki R, Honkanen A, Rosenberg PH, Laurie DJ, Pelto-Huikko M, Koistinaho J, Eriksson CJ, Korpi ER.

Alcohol Clin Exp Res. 1997 Jun;21(4):666-71.

PMID:
9194922
30.

Pharmacologic actions of subtype-selective and novel GABAergic ligands in rat lines with differential sensitivity to ethanol.

Wong G, Sarviharju M, Toropainen M, Matecka D, Korpi ER.

Pharmacol Biochem Behav. 1996 Mar;53(3):723-30.

PMID:
8866977

Supplemental Content

Loading ...
Support Center